Champions Oncology, Inc. (CSBR)

Champions Oncology Revenue

Champions Oncology had revenue of $49.22M in the twelve months ending January 31, 2024, down -8.29% year-over-year. Revenue in the quarter ending January 31, 2024 was $12.02M, a -5.90% decrease year-over-year. In the fiscal year ending April 30, 2023, Champions Oncology had annual revenue of $53.87M with 9.69% growth.

• Revenue (ttm): $49.22M
• Revenue Growth: -8.29%
• P/S Ratio: 1.39
• Revenue / Employee: $214,017
• Employees: 230
• Market Cap: 68.24M USD

Revenue History

Fiscal Year End	Revenue	Change	Growth
Apr 30, 2023	53.87M	4.76M	9.69%
Apr 30, 2022	49.11M	8.07M	19.66%
Apr 30, 2021	41.04M	8.92M	27.76%
Apr 30, 2020	32.12M	5.06M	18.68%
Apr 30, 2019	27.07M	6.83M	33.72%
Apr 30, 2018	20.24M	4.83M	31.34%
Apr 30, 2017	15.41M	4.23M	37.82%
Apr 30, 2016	11.18M	2.32M	26.16%
Apr 30, 2015	8.86M	-2.69M	-23.26%
Apr 30, 2014	11.55M	3.23M	38.77%
Apr 30, 2013	8.32M	1.17M	16.42%
Apr 30, 2012	7.15M	267.00K	3.88%
Apr 30, 2011	6.88M	1.99M	40.65%
Apr 30, 2010	4.89M	1.18M	31.89%
Apr 30, 2009	3.71M	2.31M	165.00%
Apr 30, 2008	1.40M	-	-
Apr 30, 2007	0	-	-
Apr 30, 2006	0	-	-

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.